U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"That the automobile has practically reached the limit of its development is suggested by the fact that during the past year no improvements of a radical nature have been introduced."

Scientific American ; Jan. 2 edition, 1909

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 435/21 - Involving phosphatase


Subclass of Class 435 - Chemistry: molecular biology and microbiology
Definition: Subject matter where the material to be measured or tested
No. of patents: 634
Last issue date: 01/10/2012


          9            
NumberTitleIssue Date
5856111Methods for identifying modulators of insulin receptor phosphorylation
The present invention relates to cell lines useful for the screening and identification of compounds that by modulating phosphotyrosine phosphatase activity, modulate insulin receptor type tyrosine kinase mediated signal transduction. Genetically engineer...
01/05/1999
5853974Enhancement of alkaline phosphatase with SDS in chemiluminescent substrates
Methods and compositions for enhancing the chemiluminescence from a stable 1,2-dioxetane triggered to produce a chemiluminescence are disclosed. Indirect, competitive nucleic acid hybridization assay formats are also described that employ these methods an...
12/29/1998
5851786Product and process to regulate actin polymerization
The present invention relates to methods useful for identifying compounds capable of specifically regulating actin polymerization, stress fiber formation or focal adhesion assembly by regulating G򳄒 and/or G򳄓 activity ...
12/22/1998
5849495Chemiluminescent energy transfer assays
A chemiluminescent assays for the determination of the presence or amount of a biopolymer in bound assays using 1,2-dioxetanes in connection with AttoPhos™ as chemiluminescent substrates for enzyme-labeled targets or probes is provided. Further disclose...
12/15/1998
5846753Chemiluminescence-based method for rapid and sensitive in-situ detection of organophosphorus compounds and metal ions
A method of detecting the presence of a substance being monitored in a medium, selected from the group of substances including organophosphorus compounds and the metal ions Zn, Be and Bi, including the steps of: providing a 1,2-dioxetane phenyl phosphate ...
12/08/1998
5840505Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells
An in vivo method for depleting mammalian cells of adenosine 5'-monophosphate (AMP) useful in the treatment of certain cancers is provided. According to the method, a population of cells is obtained from a host and assayed for loss of methylthioadenosine ...
11/24/1998
5830666Method of detecting nucleic acids or the like
A method of detecting nucleic acids, proteins, or protein nucleic acid complexes. The method includes binding an enzyme, such as phosphatase, to a specimen of the nucleic acid, protein, or protein nucleic acid complex. The enzyme is then reacted with a fl...
11/03/1998
5831065Kits for DNA sequencing by stepwise ligation and cleavage
The invention provides a method of nucleic acid sequence analysis based on repeated cycles of ligation to and cleavage of probes at the terminus of a target polynucleotide. At each such cycle one or more terminal nucleotides are identified and one or more...
11/03/1998
5830742TNF-଱ converting enzyme
A metalloprotease that converts TNF-଱ from the 26 kD cell form to the 17 kD form has been isolated and purified and the cDNA sequence known. In particular, the protease has a molecular weight of approximately 80 kD. The isolated and purified proteas...
11/03/1998
5831102Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes
Enzymatically cleavable chemiluminescent 1,2-dioxetane compounds capable of producing light energy when decomposed, substantially stable at room temperature before a bond by which an enzymatically cleavable labile substituent thereof is intentionally clea...
11/03/1998
5827645Homocysteine assay
The invention relates to a method for assaying homocysteine in a sample such as blood, plasma, or urine, which comprises the steps of contacting the sample with a homocysteine converting enzyme and at least one substrate for the enzyme other than homocyst...
10/27/1998
5821061Method and reagent for detecting a ligand in a sample
A novel alkaline phosphatase and a method for the production of the alkaline phosphatase are described. A method for detecting a ligand in a sample and a method for analyzing the sequence of nucleic acid in a sample using the alkaline phosphatase are also...
10/13/1998
5821075Nucleotide sequences for novel protein tyrosine phosphatases
The invention relates to the cloning of two novel protein tyrosine phosphatases. Nucleic acid sequences encoding these phosphatases (PTPL1 and GLM-2) as well as anti-sense sequences are also provided. The recombinantly produced PTPL1 and GLM-2 proteins al...
10/13/1998
5817454Portable apparatus and method for detection of methylxanthine chemical species
A portable apparatus for detecting the presence of at least one methylxanthine chemical species such as caffeine or theophylline in a beverage comprises a first portion comprising an effective concentration of phosphodiesterase enzyme, a second portion co...
10/06/1998
5801006Use of NADPH and NADH analogs in the measurement of enzyme activities and metabolites
Kits and methods for measuring enzyme activities and metabolites using NADH and NADPH analogs are disclosed. The analogs have extended stability in aqueous solutions and can used as replacements for NADH or NADPH cofactors in analytical procedures. Prefer...
09/01/1998
5801000Detection and isolation of receptors
Disclosed is a method of isolating a ligand from a sample, the method including: providing a hybrid molecule including the receptor for the ligand covalently bonded to the first member of a specific binding pair; contacting sample with the hybrid molecule...
09/01/1998
5801007Methods for calibrating chemical assays
Methods for internally and externally photostandardizing chemical assays, e.g. an ATP-bioluminescence assay. A pre-determined amount of a photosensitive derivative of the analyte of interest is used in the assay protocol which releases a known amount of t...
09/01/1998
5795713Methods for identifying inducers and inhibitors of programmed cell death
Methods for identifying inducers and inhibitors of programmed cell death in a cell-free system are described. The methods exploit the finding that programmed cell death is accompanied by shutdown of cellular protein synthesis and by phosphorylation of eIF...
08/18/1998
5789186Marker for cerebral apoplexy
A sample is treated with a phosphoglyceric acid mutase (PGAM) inhibitor (polythionic acid (salt) such as potassium tetrathionate) to inactivate the M-type isozyme activity and the B-type PGAM is quantified by determining PGAM isozymes by a rate assay. The...
08/04/1998
5783410Bacteria identification method and apparatus
The present invention discloses a bacteria-coding identification method,bacteria biochemical properties identifying papers which detect the biological properties using this method, and apparatus or means useful for identifying the genus and species of bac...
07/21/1998
5773237Method for determining tyrosine kinase activity
The subject invention provides for nucleotide sequences encoding polypeptide p62 and derivatives thereof. Another aspect of the subject invention also provides for methods of purifying p62 and derivatives thereof from cells naturally producing p62 and fro...
06/30/1998
5773226Recombinant calf intestinal alkaline phosphatase
The invention relates to isolated nucleic acids encoding recombinant calf intestinal alkaline phosphatase. Expression vectors and host cells transformed or transfected with such vectors are also provided. The invention further provides multifunctional pol...
06/30/1998
5770391Reagents and methods for use in bioluminescence
The subject invention pertains to a combination of enzyme activities comprising an ATP-degrading enzyme and one or more enzymes capable of degrading substances, other than ATP, that are substrates for the light-emitting reaction of firefly luciferase. The...
06/23/1998
5763158Detection of multiple antigens or antibodies
A method for simultaneously testing a sample for the presence of multiple rget antigens or antibodies in the sample, which comprises presenting the sample to a plurality of different binding sites, wherein at least two of the sites are binding sites for d...
06/09/1998
5763198Screening assays for compounds
The invention is directed to rapid and quantitative assay systems for screening test compounds for their ability to modulate tyrosine kinase or phosphatase activities involved in signal transduction by determining the tyrosine phosphorylation state of a p...
06/09/1998
5756303Culture medium and a microbiological test method employing the same
The present invention provides a culture medium for microbiological tests prepared by treating medium components containing adenosine triphosphate (ATP) with an acidic phosphatase as well as a microbiological test method characterized by using said cultur...
05/26/1998
5753436Chemiluminescent energy transfer assays
A chemiluminescent assays for the determination of the presence or amount of a biopolymer in bound assays using 1,2-dioxetanes in connection with AttoPhos™ as chemiluminescent substrates for enzyme-labeled targets or probes is provided. Further disclose...
05/19/1998
5753443Crystallized formulation for staining DNA, its preparation and kit
A process is disclosed for making a crystallized formulation for staining nuclear DNA to be used in flow cytometery. The crystallized DNA staining formulation and a kit containing the crystallized DNA staining formulation are provided. The staining formul...
05/19/1998
5750358Quantitative clotting assay for activated factor VII
An assay for activated factor VII (factor VIIa) has been developed using truncated tissue factor (tTF), a soluble mutant form of tissue factor (TF) that retains the cofactor function of TF toward factor VIIa. Unlike full-length TF, however, tTF appears no...
05/12/1998
5741654Immunoassay for the detection of human autoantibodies
An assay and test kit of the determination of LKM-1 autoantibodies in test samples suspected of containing anti-LKM-1 autoantibodies. The method uses a solid phase which preferably is a microparticle. The method is standardized and can be performed in aut...
04/21/1998
5731158Catalyzed reporter deposition
The present invention concerns a method to catalyze reporter deposition to improve detection or quantitation of an analyte in a sample by amplifying the detector signal which comprises reacting an analyte dependent enzyme activation system with a conjugat...
03/24/1998
5716786VNTR probes and methods of using thereof
According to the process of the invention, sets of restriction fragments from the DNA of an individual are prepared, these restriction fragments being separated by size. Probes are prepared by enzymatic hydrolysis of DNA from a genome bank of the species ...
02/10/1998
5707559Chemiluminescent 1,2-dioxetane compounds
Novel light producing 1,2-dioxetanes are described of the formula ##STR1## wherein ArOX is an aryl ring substituted with an X oxy group and A are passive organic groups which allow the 1,2-dioxetane to produce light when triggered by removing X. X is...
01/13/1998
5695950Method of screening for antimitotic compounds using the cdc25 tyrosine phosphatase
A method of identifying compounds or molecules which alter (enhance or inhibit) stimulation of kinase activity of pre-MPF and, thus, alter (enhance or inhibit) activation of MPF and entry into mitosis. The present method thus makes it possible to identify...
12/09/1997
5674716DNA sequencing
A method for sequencing a strand of DNA, including the steps of: providing the strand of DNA; annealing the strand with a primer able to hybridize to the strand to give an annealed mixture; incubating the mixture with a deoxyribonucleoside triphosphate, a...
10/07/1997
5670346Modifying nucleotide analogues
Fluorescently labelled dideoxynucleoside triphosphates are widely used as chain-terminators in Sanger dideoxy sequencing operations. But these unincorporated dye-terminators migrate in an electrophoresis gel and obscure the desired sequence ladder. This i...
09/23/1997
5656448Dipstick immunoassay device
The invention pertains to dipstick immunoassay devices. The device comprises a base member and a single, combined sample contact zone and test zone, wherein the test zone incorporates the use of symbols to detect analytes in a sample of biological fluid. ...
08/12/1997
5654152Method of measuring enzyme activity by using a column having an immobilized substrate
Enzyme activity is measured promptly with a high accuracy by introducing an enzyme, the activity of which is to be measured, into a column comprising a hollow tube packed with a filler comprising a support and a substrate that can be recognized by the enz...
08/05/1997
5631127Enzymatic assay for homocysteine and a kit therefor
The invention relates to a method for assaying homocysteine in a sample such as blood, plasma or urine, which comprises the steps of contacting the sample with a homocysteine converting enzyme and at least one substrate for the enzyme other than homocyste...
05/20/1997
5618736Method for using synthesized kaolinite as carrier for bioreactor, a composite body composed substantially of synthesized kaolinite as carrier and enzyme carried on synthesized kaolinite, and bioreactor system using such a composite body
A process using hydrothermally synthesized porous kaolinite as a carrier for use in a bioreactor. A carrier-biocatalyst composite body for use in a bioreactor, includes the synthesized kaolinite as a carrier and a biocatalyst fixed onto the synthesized ka...
04/08/1997
          9            
 
Sign InRegister
Username  
Password   
forgot password?